Combination Therapy of Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-γ Ligand, and NMDA Receptor Antagonist (MK-801) on Experimental Embolic Stroke in Rats
Mohammad Allahtavakoli, Alireza Shabanzadeh, Ali Roohbakhsh, Aliasghar PourshanazariVolume:
101
Year:
2007
Language:
english
Pages:
6
DOI:
10.1111/j.1742-7843.2007.00127.x
File:
PDF, 129 KB
english, 2007